Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 05, 2025 Reported Q3 2025 Total Revenues of $148.4 Million, Driven by Continued FIRDAPSE(R) Growth, Strong AGAMREE(R) Uptake and Growth, and Continued Demand for FYCOMPA(R) Raising Full-Year 2025 Total Revenue Guidance to between $565 Million and $585 Million, Reflecting Better than […]